National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

STATUTORY RULES.

1962. No. 34

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1961.*

I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1961.

Dated this twelfth day of April, 1962.

DE L’ISLE

Governor-General,

By His Excellency’s Command,

Minister of State for Health.

AMENDMENTS OF THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS)

REGULATIONS. 

Commencement.

1. These Regulations shall come into operation on the first day of May, 1962.

Standards of composition and purity of pharmaceutical benefits and additives.

2. Regulation 35 of the National Health (Pharmaceutical Benefits) Regulations is amended by adding at the end thereof the following sub-regulation:—

“(6.) Where the letters ‘B.P.C.1954’ appear after the name of the pharmaceutical benefit or the additive, the standards of composition and purity are those constituted by the description of that pharmaceutical benefit and of its ingredients, or of that additive, as the case may be, in the edition of the book called the British Pharmaceutical Codex published by direction of the Council of the Pharmaceutical Society of Great Britain in the year 1954.”.

* Notified in the Commonwealth Gazette on 15th April, 1962.

  Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; and 1961, Nos. 59 and 137.

1699/62.—PRICE 1S 9/6.4.1962.

First, Second, Third, Fourth, and Fifth Schedules.

3. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—

FIRST SCHEDULE.

Regulation 10.

DRUGS AND MEDICINAL PREPARATIONS IN THE BRITISH PHARMACOPOEIA THAT ARE NOT TO BE SUPPLIED AS, OR USED IN, PHARMACEUTICAL BENEFITS EXCEPT AS SPECIALLY PROVIDED.

Absorbable Gelatin Sponge.

Acetazolamide.

Acetomenaphthone.

Adrenaline Acid Tartrate.

Alcohol.

Amethocaine Hydrochloride.

Amethocaine Injection.

Amodiaquine Hydrochloride.

Amphetamine.

Amphetamine Sulphate.

Amylobarbitone.

Amylobarbitone Sodium.

Amylobarbitone Sodium Tablets.

Antimony Potassium Tartrate.

Antimony Sodium Tartrate.

Apomorphine Hydrochloride.

Azovan Blue.

Bacillus Calmette-Guerin Vaccine.

Bacitracin.

Bemegride.

Benzhexol Hydrochloride.

Bismuth Oxychloride.

Bismuth Oxychloride Injection.

Bismuth Sodium Tartrate.

Busulphan.

Butobarbitone.

Calciferol.

Caraway.

Carbachol.

Carbimazole.

Carbon Dioxide.

Cardamom Fruit.

Catgut, sterlized surgical.

Cellulose Oxidized.

Chlorcyclizine Hydrochloride.

Chorionic Gonadotrophin.

Chloroquine Phosphate.

Chloroquine Sulphate.

Chlorothiazide.

Chloroxylenol.

Chlortetracycline Injection.

Cinchocaine Hydrochloride.

Cinnamon.

Cochineal.

Cod Liver Oil.

Colchicine.

Coriander.

Corticotrophin.

Cresol.

Cyanocobalamin.

Cyclobarbitone.

Cyclopropane.

Dapsone.

Dexamphetamine Sulphate.

Dextran Injection.

Dextran Sulphate.

Dextran Sulphate Injection.

Diethylcarbamazine Citrate.

Digitalis Leaf.

Dimercaprol.

Diodone Injection.

Dithranol.

Emetine and Bismuth Iodide.

Emetine Hydrochloride.

Ergometrine Maleate.

Ether Vinyl.

Ethinyloestradiol.

Ethisterone.

Ethopropazine Hydrochloride.

Ethyl Biscoumacetate.

Ethyl Chloride.

Ethylenediamine Hydrate.

Gallamine Triethiodide.

Gallamine Injection.

Gentian.

Gentian Compound Infusion.

Ginger.

Halothane.

Hamamelis.

Helium.

Heparin.

Hexamethonium Tartrate.

Histamine Acid Phosphate.

Human Blood, whole.

Human Red Blood Corpuscles, concentrated.

Human Fibrin Foam.

Human Fibrinogen.

Human Gamma Globulin.

Human Gamma Globulin Injection.

Human Serum, dried.

Human Serum, liquid.

Human Plasma, dried.

Human Thrombin.

Hydrocortisone Acetate.

Hydrocortisone Acetate Ointment.

Hydrocortisone Hydrogen Succinate.

Hydrocortisone Ointment.

Hydrogen Peroxide Solution, strong.

Hydroxychloroquine Sulphate.

Hyoscine Eye Ointment.

Hyoscyamus.

Iodised Oil Injection.

Iodoxyl.

Iopanoic Acid.

Iopanoic Acid Tablets.

Ipecacuanha.

Ipecacuanha, prepared.

Isoniazid

Lead Acetate.

First Schedule—continued.

Lead Monoxide.

Lemon Peel, dried.

Lemon Peel, fresh.

Leptazol.

Lignocaine and Adrenaline Injection.

Lignocaine Hydrochloride.

Lignocaine Hydrochloride Injection.

Liothyronine Sodium.

Liothyronine Tablets.

Lucanthone Hydrochloride.

Male Fern.

Maleic Acid.

Mannitol.

Mepacrine Hydrochloride.

Mephenesin.

Mephenesin Injection.

Mercaptopurine.

Mercuric Oxide, yellow.

Mercury.

Mersalyl Acid.

Methadone Hydrochloride.

Methoin.

Methyltestosterone.

Methylamphetamine Hydrochloride.

Methylthiouracil.

Mustine Hydrochloride.

Nalorphine Hydrobromide.

Naphazoline Hydrochloride.

Neostigmine Bromide.

Neostigmine Methylsulphate.

Nicotinic Acid.

Nikethamide.

Nitrous Oxide.

Nux Vomica.

Oestradiol Benzoate.

Opium.

Opium, powdered.

Orange Peel, dried bitter.

Orange Peel, fresh bitter.

Ouabain.

Oxygen.

Oxytetracycline Dihydrate.

Paramethadione.

Pentamidine Injection.

Pentamidine Isethionate.

Pethidine Tablets.

Phenindamine Tartrate.

Phenindione.

Pheniodol.

Phenolphthalein Tablets.

Phenolsulphonphthalein.

Phytomenadione.

Phytomenadione Capsules.

Picrotoxin.

Poliomyelitis Vaccine.

Potassium Perchlorate.

Prednisone Acetate.

Primaquine Phosphate.

Primidone.

Probenecid.

Procyclidine Hydrochloride.

Procaine and Adrenaline Injection.

Progesterone.

Proguanil Hydrochloride.

Propyliodone.

Propyliodone Injection.

Propyliodone Oily Injection.

Propyl Thirouracil.

Pyridostigmine Bromide.

Pyrimethamine.

Pyrimethamine Tablets.

Quillaia.

Senna Leaf.

Soda Lime.

Sodium Aminosalicylate Tablets.

Sodium Antimonylgluconate.

Sodium Antimonylgluconate Injection.

Sodium Aurothiomalate.

Sodium Radio-iodide (131I) Injection.

Sodium Radio-iodide (131I) Solution.

Sodium Radiophosphate (82P) Injection.

Sodium Radiophosphate (82P) Solution.

Sodium Stibogluconate.

Sodium Stibogluconate Injection.

Solapsone.

Solapsone Tablets.

Stibophen.

Sulphadimidine Sodium.

Suramin.

Suxamethonium Bromide.

Suxamethonium Chloride.

Suxamethonium Chloride Injection.

Testosterone.

Tetrachloroethylene.

Thiomersal.

Thiopentone Sodium.

Thiopentone Injection.

Thyroid.

Thyroxine Sodium.

Tolazoline Hydrochloride.

Tolbutamide.

Trichloroethylene.

Tryparsamide.

Tuberculin, old.

Tuberculin Purified Protein Derivative.

Tubocurarine Chloride.

Tubocurarine Injection.

Typhoid-Paratyphoid A and B and Cholera Vaccine.

Typhoid-Paratyphoid A and B and Tetanus Vaccine.

Yellow Fever Vaccine.

SECOND SCHEDULE.

Regulation 10 (3.).

DRUGS AND MEDICINAL PREPARATIONS THAT ARE PHARMACEUTICAL BENEFITS ONLY WHEN PRESCRIBED FOR USE IN A DETERMINED FORM OR IN ALLOWABLE COMPOUNDS.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Dried Aluminium Hydroxide Gel, B.P.	Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Aluminium Hydroxide Gel. B.P. .............	Aluminium Hydroxide Gel. B.P. with Light Magnesia B.P.
Aluminium Hydroxide Gel. B.P. with Magnesium Trisilicate B.P. and Magnesium Hydroxide B.P.
Aluminium Powder ...............................	Aluminium Powder with Zinc Oxide B.P. and Liquid Paraffin B.P.
Amiphenazole Hydrobromide ................	—
Amiphenazole Hydrochloride A.P.F. 1955	—
Aneurine Hydrochloride B.P. .................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Ascorbic Acid B.P. ................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Attapulgite ............................................	Dihydrostreptomycin Sulphate, Attapulgite, Pectin and Hydrated Alumina Powder
Bendrofluazide ......................................	—
Benethamine Penicillin ..........................	Benethamine Penicillin with Procaine Penicillin B.P. and Benzylpenicillin Sodium B.P.
Benzalkonium Chloride .........................	—
Benzathine Penicillin B.P. ......................	Procaine Penicillin B.P. with Benzylpenicillin B.P. and Benzathine Penicillin B.P.
Benzylpenicillin B.P. .............................	Fortified Procaine Penicillin Injection B.P.
Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
Procaine Penicillin B.P. with Benzylpenicillin B.P. and Benzathine Penicillin B.P.
Benzylpenicillin Sodium B.P. .................	Streptomycin Sulphate B.P. with Benzylpenicillin Sodium B.P.
Benethamine Penicillin with Procaine Penicillin B.P. and Benzylpenicillin Sodium B.P.
Bismuth Subnitrate B.P.C. .....................	Resornicol B.P. with Bismuth Subnitrate B.P.C. Zinc Oxide B.P., Starch B.P., Cade Oil B.P., Wool Fat B.P., Sodium Metabisulphite, Water, Hard Paraffin B.P. and Yellow Soft Paraffin B.P.
Butabarbital Sodium ..............................	—
Carbromal B.P. .....................................	Pentobarbitone Sodium B.P. with Carbromal B.P.
Chloramphenicol B.P. ............................	Chloramphenicol B.P. with Borate Buffer and Sterile Distilled Water
Chloramphenicol B.P. with Propylene Glycol B.P.
Chloramphenicol B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Chlorpromazine Hydrochloride B.P. .......	—
Chlortetracycline Calcium ......................	—
Chlortetracycline Hydrochloride B.P. .....	Chlortetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Clemizole .............................................	—

SECOND SCHEDULE—continued.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Cortisone Acetate B.P. ..........................
Demethylchlortetracycline Hydrochloride	—
Dexamethasone Sodium Phosphate ........	—
Dextrochlorpheniramine Maleate ...........	—
Dicyclomine Hydrochloride ..................	—
Dienoestrol B.P. ...................................	—
Diethyl Dithiolisophthalate ...................	—
Dihydrostreptomycin Sulphate	Dihydrostreptomycin Sulphate, Attapulgite, Pectin and Hydrated Alumina Powder
Diiodohydroxyquinoline B.P. ................	—
Diphtheria and Pertussis Vaccine B.P.	Diphtheria, Tetanus and Pertussis Vaccine B.P.
Diphtheria Vaccine B.P. ........................	Diptheria and Pertussis Vaccine B.P.
Diphtheria, Tetanus and Pertussis Vaccine B.P.
Diphtheria and Tetanus Vaccine B.P.
Diphtheria and Tetanus Vaccine B.P. .....	—
Ergotamine Tartrate B.P. .......................	Ergotamine Tartrate B.P. with Caffeine B.P.
Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. and Diphenhydramine Hydrochloride B.P.
Erythromycin B.P. ................................	—
Ethotoin ...............................................	—
Ferrous Aminoacetosulphate .................	—
Ferrous Succinate .................................	—
Glucose Indicator .................................	—
Griseofulvin .........................................	—
Guanethidine Sodium ...........................	—
Haemophilus Influenza Bacterial Serum	—
Hamamelis Dry Extract .........................	Hamamelis Dry Extract with Zinc Oxide B.P. and Theobroma Oil B.P.
Hexocyclium Methyl Sulphate ..............	—
Hydrated Alumina Powder ....................	Dihydrostreptomycin Sulphate, Attapulgite, Pectin and Hydrated Alumina Powder
Hydrocortisone B.P. .............................	—
Hydrocortisone Sodium Succinate .........	—
Isoprenaline Hydrochloride ...................	—
Isopropamide Iodide .............................	—
Levallorphan Tartrate ...........................	Levallorphan Tartrate with Pethidine Hydrochloride B.P.
Lofenalac .............................................	—
Meclozine Hydrochloride B.P.C. ...........	—
Mercuric Oxide Eye Ointment B.P. .......	—
Methazolamide .....................................	—
Methscopolamine Bromide ...................	—
Methyclothiazide ..................................	—
Methylphenobarbitone B.P.C. ...............	—
Methylprednisolone ..............................	—
Minafen ...............................................	—
Naphazoline Nitrate B.P. ......................	Antazoline Hydrocloride B.P. with Naphazoline Nitrate B.P.
Neomycin Sulphate B.P., Eye Drops ......	Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base
Neomycin Sulphate B.P. with Bacitracin B.P. and Polymyxin B. Sulphate B.P.
Nicotinamide B.P. ................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Oestrone ..............................................	—
Oleandomycin ......................................	Tetracycline with Oleandomycin
Oleoresin Capsicum ..............................	Bile Salts with Cascara Sagrada B.P., Phenolphthalein B.P. and Oleoresin Capsicum

SECOND SCHEDULE—continued.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Oxyphencyclimine Hydrochloride .........	—
Oxyphenonium Bromide .......................	—
Oxytetracycline Hydrochloride B.P. ......	Oxytetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Papaveretum B.P.C. ..............................	Papaveretum B.P.C. with Hyoscine Hydrobromide B.P.
Pancreatin B.P. .....................................	—
Pectin ...................................................	Dihydrostreptomycin Sulphate, Attapulgite, Pectin and Hydrated Alumina Powder
Pempidine Tartrate ...............................	—
Pentolinium Tartrate B.P. ......................	Pentolinium Tartrate B.P. with Ephedrine B.P.
Pethidine Hydrochloride B.P. ................	Pethidine Hydrochloride B.P. with Hyoscine Hydrobromide B.P.
Pethidine Hydrochloride B.P. with Levallorphan Tartrate
Pertussis Vaccine B.P. ..........................	Diphtheria, Tetanus and Pertussis Vaccine B.P.
Diphtheria and Pertussis Vaccine B.P.
Phenoxymethylpenicillin B.P. ...............	—
Phenoxymethylpenicillin (Benzathine Salt)	—
Phenoxymethylpenicillin Calcium B.P.	—
Phenoxymethylpenicillin (Hydrabamine Salt)	—
Phenoxymethylpenicillin Potassium B.P.	—
Pipenzolate ..........................................	—
Polymyxin B. Sulphate B.P. ..................	Polymyxin B. Sulphate B.P. with Mucilage of Methylcellulose and Distilled Water B.P.
Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base
Polymyxin B. Sulphate B.P. with Ophthalmic Phosphate Buffer
Polymyxin B. Sulphate B.P. with Acetic Acid B.P. and Propylene Glycol B.P.
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Bacitracin B.P.
Polymyxin B. Sulphate B.P. with Tetracycline Hydrochloride
Prednisolone B.P. .................................	Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Prednisolone B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Prednisolone Disodium Phosphate .........	—
Prednisone B.P. ....................................	Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Procaine Hydrochloride B.P.	Procaine Hydrochloride B.P. in Normal Saline
Tetracycline and Procaine Injection B.P.
Pyrazinamide .......................................	—
Pyrvinium Pamoate ..............................	—
Pyridine Aldoxime Methiodide ..............	—
Pyrimido-Pyrimidine ............................	—
Pyrrolidino-Methyl—Tetracycline .........	—
Rauwolfia Alkaloids .............................	—
Reserpine B.P. .....................................	—
Riboflavine B.P. ...................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Sobee ...................................................	—

SECOND SCHEDULE—continued.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Sodium Chloride B.P. with Potassium Chloride B.P. and Hydrated Calcium Chloride B.P. in Water for Injection B.P.	Sodium Chloride B.P. with Potassium Chloride B.P., Hydrated Calcium Chloride B.P., Water for Injection B.P. and Dextrose B.P.
Compound Sodium Lactate Injection B.P.	Compound Sodium Lactate Injection B.P. with Dextrose B.P.
Sodium Lauryl Sulphate B.P. ................	Emulsifying Wax B.P.
Streptomycin Sulphate B.P. ...................	Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
Benzylpenicillin Sodium B.P. with Streptomycin Sulphate B.P.
Streptomycin Sulphate B.P. with Normal Saline
Sulphadimidine B.P. .............................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphadimidine B.P.
Sulphaguanidine B.P. ...........................	Sulphaguanidine B.P. and Streptomycin Sulphate B.P.
Sulphamerazine B.P. .............................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphadimidine B.P.
Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphathiazole
Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphacetamide
Sulphacetamide ....................................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphacetamide
Sulphathiazole ......................................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphathiazole
Tacrine ................................................	Tacrine with Morphine
Terpineol B.P. ......................................	Solution of Chloroxylenol B.P.
Tetanus Vaccine B.P. ............................	Diphtheria, Tetanus and Pertussis Vaccine B.P.
Tetracycline Hydrochloride B.P. ............	Tetracycline Hydrochloride B.P. with Nystatin
Tetracycline and Procaine Injection B.P.
Tetracycline Hydrochloride B.P. with a buffering agent
Tetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Tetracycline .........................................	Tetracycline with Oleandomycin
Thenalidine ..........................................	Thenalidine with Calcium Lactate B.P. and Calcium Gluconate B.P.
Theobroma Prepared B.P.C. ..................	Calcium Gluconate B.P. with Sucrose B.P., Vanillin B.P. and Theobroma Prepared B.P.C.
Triamcinolone ......................................	—
Trifluoperazine .....................................	—
Tricyclamol Chloride ............................	—
Tripelennamine Hydrochloride ..............	—
Troxidone B.P. .....................................	—
Typhoid Para-Typhoid A and B Vaccine B.P.	Typhoid Para-Typhoid A, B and C Vaccine B.P.
Tyrothricin ...........................................	Tyrothricin with a buffering agent
Concentrated Vitamin A Solution B.P.	Concentrated Vitamins A and D Solution B.P.
Concentrated Vitamin D Solution B.P.	Concentrated Vitamins A and D Solution B.P.
Vitamin D ............................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Yellow Mercuric Oxide B.P. .................	Mercuric Oxide Eye Ointment B.P.

THIRD SCHEDULE.

Regulation 11.

PHARMACEUTICAL BENEFITS ADDITIONAL TO PHARMACEUTICAL BENEFITS IN THE BRITISH PHARMACOPOEIA.

Acetazolamide Sodium.

Acetyl-Sulphamethoxypyridazine.

Aconite Liniment, B.P.C.

Acriflavine, B.P. 1948.

Adrenaline Hydrochloride Solution, B.P. 1953.

Adrenaline in Oil.

Adrenaline Mucate.

Agar, B.P.C.

Aloes Pill, B.P. 1948.

Aloin, B.P. 1953.

Aloxidone.

Aluminium Acetate Solution, B.P.C.

Aluminium Powder.

Amaranth Solution A.P.F.

Amaranth Solution B.P.C. 1954.

Amidopyrin, B.P.C. 1954.

Amiphenazole Hydrobromide.

Amiphenazole Hydrochloride, A.P.F. 1955.

Ammonium Acetate, Strong Solution, B.P. 1953.

Ammonium Bicarbonate, B.P. 1953.

Ammonium Bromide, B.P.C.

Amphotericin B.

Androstanolone.

Aniseed Water, concentrated, B.P.C.

Spirit of Aniseed, B.P.C. 1949.

Aromatic Ammonia Spirit, B.P. 1953.

Attapulgite.

Aurothioglucose.

Balsam of Peru, B.P.C.

Beeswax, Yellow, B.P.C.

Belladonna Suppository, B.P. 1948.

Bendrofluazide.

Benzalkonium Chloride.

Benzoinated Lard, B.P.C. 1954.

Bephenium Hydroxynaphthoate.

Betamethasone.

Bismuth Carbonate, B.P. 1953.

Bismuth Glycollylarsanilate.

Bismuth Subgallate, B.P. 1953.

Bismuth Subnitrate, B.P.C.

Borate Buffer.

Bretylium Tosylate.

Brown Snake Antivenene.

Buchu Concentrated Infusion, B.P.C. 1954.

Butabarbital Sodium.

Butyl Aminobenzoate, B.P. 1953.

Caffeine Citrate, B.P.C.

Spirit of Cajuput, B.P. 1948.

Calamine Cream, A.P.F.

Calcium Aurothiomalate.

Calcium Di-Oxytetracycline.

Calcium. Aminosalicylate, B.P.C.

Calcium Phosphate, B.P. 1953.

Calumba Concentrated Infusion, B.P. 1948.

Calumba Tincture, B.P. 1948.

Camphor Water, concentrated, B.P.C. 1949.

Capsicum Ointment, B.P.C.

Capsicum Tincture, B.P.C.

Caramiphen Hydrochloride.

Oil of Caraway, B.P.C.

Cardamom Aromatic Tincture, B.P.C.

Carmine Solution, A.P.F.

Catechu Tincture, B.P.C.

Cetyl Alcohol Compound.

Charcoal.

Chiniofon, B.P. 1948.

Chlorambucil.

Chlorazanil.

Chlormerodrin.

Chlorobenzol Disulphonamide.

Chloroform Water, concentrated, B.P.C.

Chlorpheniramine Maleate.

Chlorpropamide.

Chlortetracycline Calcium.

Chlorthalidone.

Spirit of Cinnamon, B.P.C. 1949.

Clemizole Hydrochloride.

Cloves, Concentrated Infusion, B.P.C. 1954.

Tincture of Cochineal, B.P. 1948.

Coconut Oil, B.P.C. 1949.

Codeine, B.P.C. 1954.

Cod Liver Oil Emulsion, B.P., 1953.

Colchicine Salicylate.

Colocynth and Hyoscyamus Pill, B.P.C.

Colocynth, B.P.C.

Colocynth Compound Powder Extract, B.P.C.

Compound Effervescent Powder, B.P. 1953.

Creosote, B.P. 1953.

Crude Coal Tar.

Tincture of Cudbear, A.P.F. 1947.

Cyclophosphamide.

Cycloserine.

Cycrimine Hydrochloride.

Cymogran.

Cyproheptadine.

D-Cycloserine.

Darrow’s Solution.

Demecarium Bromide.

Demethylchlortetracycline Hydrochloride.

Desacetyl-Lanatoside, C.

Dexamethasone

Dexamethasone odium Phosphate.

Dextran Iron.

Dextrin Iron.

Dextrochlorpheniramine Maleate.

Dichlorphenamide.

Dicyclomine Hydrochloride.

Diethazine Hydrochloride.

Diethyl Dithiolisophthalate.

Diloxanide Furoate.

Digitoxin, B.P.C.

Dihydroergotamine.

Dihydromorphinone Hydrochloride, B.P.C. 1949.

THIRD SCHEDULE—continued.

Diphenylpyraline Hydrochloride.

Diphenylthiourea.

Diphtheria Toxoid Purified.

Disodium Diethylstilboestrol Diphosphate.

Disodium Dihydrogen Versenate.

Dithiazanine Iodide.

Ephedrine Sulphate, B.P.C. 1954.

Ergot Liquid Extract, B.P.C. 1954.

Erythrityltetranitrate, B.P.C. 1949.

Erythromycin Glucoheptonate.

Erythromycin Propionate.

Erythromycin Stearate.

Ethotoin.

Ethoxzolamide.

Ethylidene Dicoumarin.

Ethylnoradrenaline.

Ferric Hydroxide.

Ferric Chloride Solution, B.P.C.

Ferrous Aminoacetosulphate.

Ferrous Phosphate Compound Syrup, B.P.C.

Ferrous Phosphate with Quinine and Strychnine Syrup, B.P.C.

Ferrous Succinate.

Fludrocortisone Acetate.

Fluoxymesterone.

Formyl-Tetrahydropteroyl Glutamic Acid.

Fructose, B.P. 1948.

Gall with Opium Ointment, B.P.C.

Gelsemium Tincture, B.P.C.

Gentian Violet.

Glucose Indicator.

Glucose Liquid, B.P. 1953.

Glutethimide, B.P.C.

Glycerophosphates Compound Syrup, A.P.F.

Griseofulvin.

Guanethidine Sodium.

Guanethidine Sulphate.

Haemophilus Influenza Bacterial Serum.

Hamamelis Dry Extract.

Heparin Retard.

Hexachlorophene, 3% with Entsufon.

Hexachlorophene, 3% with Lissapol.

Hexachlorophene, 1.5% with Soap Solution.

Hexachlorothiazide.

Hexocyclium Methyl Sulphate.

Hexoestrol.

Honey, Purified, B.P.C.

Hydrated Alumina Powder.

Hydrocalciferol.

Hydrocyanic Acid Dilute, B.P.C. 1954.

Hydroflumethiazide.

Hypophosphorous Acid Dilute, B.P.C.

Insulin Isophone (N.P.H.).

Insulin Special P (Pig).

Iodochlorhydroxyquinoline.

Iodoform B.P.C.

Iodoform Suppository, B.P. 1948.

Ipomoea Resin.

Iron Carbonate Saccharated, B.P.C.

Iron Oxide Saccharated.

Iron Carbohydrate Complex.

Isoprenaline Hydrochloride.

Isopropamide Iodide.

Oil of Spike Lavender, B.P.C.

Syrup of Lemon, neutral, A.P.F.

Levallorphan Tartrate.

Levorphanol Tartrate, B.P.C.

Lobelia Ethereal Tincture, B.P.C.

Lofenalac.

Magenta, B.P.C.

Magnesium Bicarbonate Solution, B.P. 1948.

Mecamylamine.

Mecholyl Chloride.

Meclozine Hydrochloride, B.P.C.

Mephentermine Sulphate.

Mercaptomerin Sodium.

Mercuric Chloride, B.P. 1953.

Mercurous Chloride Ointment, B.P. 1948

Mercury Compound Ointment, B.P.C.

Methazolamide.

Methenamine Mandelate.

Methicillin.

Methotrexate.

Methscopolamine Bromide.

Methyclothiazide.

Methyl Androstanolone.

Methyl Atropine Nitrate.

Methylcellulose A.P.F.

Methylcellulose Mucilage, A.P.F.

Methyl Prednisolone.

Methylandrostenediol.

Methylphenobarbitone, B.P.C.

Minafen.

Myrrh, B.P.C.

Myrrh Tincture, B.P.C.

Nandrolone.

Nicoumalone.

Nitrofurantoin.

Nitromin.

Nitrous Ether Spirit, B.P.C.

Norethandrolone.

Nux Vomica Extract, Dried, B.P. 1953.

Nystatin.

Oestradiol Dipropionate.

Oestrone.

Oleandomycin.

Olcoresin Capsicum.

Orange Peel Infusion Concentrated, B.P. 1948.

Orange Peel Infusion Concentrated, Compound, B.P.C.

Ox-Bile Extract, B.P. 1948.

Oxymel, B.P.C.

Oxymel of Squill, B.P.C.

Oxyphencyclimine Hydrochloride.

Oxyphenonium Bromide.

Pancrex 5.

Para-Aminosalicylic Acid.

Paraben Ophthalmic Phosphate Buffer, A.P.F.

Paraben Ophthalmic Vehicle, A.P.F.

Papaveretum, B.P.C.

Pectin.

Pempidine Tartrate.

Benzylpenicillin in Oil.

Penicillin Benethamine.

THIRD SCHEDULE—continued.

Penicillinase.

Pentaerythritol Tetranitrate.

Penthienate.

Pertussis Prophylactic (Haemagglutinin Aluminium Phosphate Adsorbed).

Phenazone, B.P.C.

Phenethicillin.

Phenformin.

Phenoxymethylpenicillin (Benzathine

Salt).

Phenoxymethylpenicillin (Hydrabamine Salt).

Phensuximide.

Phenylbutazone.

Phenylmercuric Dinaphthylmethane Disulphonate.

Phthalylsulphacetamide.

Pholcodine, B.P.C.

Pholcodine Citrate Syrup, B.P.C.

Physostigmine Alkaloid.

Pipenzolate.

Pituitary (Posterior Lobe).

Potash Sulphurated, B.P.C.

Potassium Chlorate, B.P.C.

Prednisolone Disodium Phosphate.

Prednisolone Sodium Hemisuccinate.

Prophenpyridamine Para-Aminosalicylate.

Protamine Sulphate.

Protoveratrines A.

Pyrazinamide.

Pyridine Aldoxime Methiodide.

Pyridoxine Hydrochloride, B.P.C.

Pyrimido-Pyrimidine.

Pyrrolidino-Methyl-Tetracycline.

Pyrvinium Pamoate.

Quassia Tincture, B.P. 1948.

Tincture of Quillaia, B.P.C.

Rauwolfia Alkaloids.

Ristocetin.

Salicylazosulphapyridine.

Senega Concentrated Infusion, B.P.C.

Senna Compound Mixture, B.P.C.

Senna Leaf Concentrated Infusion, B.P.C.

Siberian Fir Oil, B.P.C. 1949.

Silver Picrate, B.P.C. 1949.

Silver Protein Mild, B.P.C.

Soap Curd, B.P.C.

Soap Hard, B.P.C.

Sobee.

Sodium Calcium Edetate.

Sodium Carbonate Exsiccated, B.P.C.

Sodium Folate.

Sodium Lactate.

Sodium Nitrite, B.P.C.

Sodium Oleate Acid.

Sodium Tauroglycocholate.

Sorbolene, A.P.F.

Spiramycin.

Spironolactone.

Syrup of Squill, B.P.C.

Squill Tincture.

Squill Vinegar, B.P. 1948.

Stearic Acid, B.P.C.

Strophanthus Tincture, B.P. 1948.

Strychnine, B.P.C.

Sulfinpyrazone.

Sulphacetamide.

Sulphadiazine Sodium.

Sulphadimethoxine.

Sulphamethoxypyridazine.

Sulphafurazole.

Sulphamethizole.

Sulphaphenazole.

Sulphathiazole.

Sulphapyridine, B.P.C.

Sulphuric Acid Dilute, B.P.C.

Sustanon.

Syntocinon.

Syrup, Red.

Tacrine.

Talc Purified, B.P.C.

Testosterone Oenanthate.

Tetanus Toxoid, Purified Aluminium Phosphate Adsorbed.

Tetracycline.

Thenalidine.

Theobromine, B.P.C.

Theobroma Prepared, B.P.C.

Thiacetazone.

Thiambutosine.

Thiouracil, B.P. 1948.

Thyrotropin.

Tiger Snake Antivenene.

Tretamine.

Triamcinolone.

Tricyclamol Chloride.

Triethanolamine, B.P.C.

Triethanolamine Trinitrate.

Triethylene Thiophosphoramide.

Trifluoperazine.

Trimetaphan Camphorsulphonate.

Trinitrophenol, B.P.C.

Triprolidine Hydrochloride.

Tyrothrycin.

Valerian Ammoniated Tincture, B.P.C.

Vasopressin Tannate in Oil.

Veriloid.

Vitamin A.

Vitamin D.

Vitamin K.

Volatile Bitter Almond Oil, B.P. 1953.

Warfarin Sodium.

FOURTH SCHEDULE.

Regulation 12.

ADDITIVES.

Acetone, B.P.C.

Alcohol, B.P.

Amethocaine Hydrochloride, B.P.

Bacitracin, B.P.

Carmine Solution, A.P.F.

Cod Liver Oil, B.P.

Oil of Caraway, B.P.C.

Oil of Citronella, B.P.C.

Xylene, B.P.C. 1949.

FIFTH SCHEDULE

Regulation 14.

PHARMACEUTICAL BENEFITS THE PRESCRIBING OF WHICH IS SUBJECT TO CONDITIONS AND RESTRICTIONS.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Amiphenazole Hydrobromide	As an antidote to barbiturate and other hypnotic poisons
Amiphenazole Hydrochloride A.P.F. 1955
Amphotericin B ....................................	Systemic fungal infections
Androstanolone ....................................	Mammary carcinoma
Aneurine Hydrochloride Tablets B.P. ....	Any disease or condition in a pensioner
Ascorbic Acid Tablets B.P. ...................	Any disease or condition in a pensioner
Bemegride Injection B.P. ......................	As an antidote to barbiturate and other hypnotic poisons
Betamethasone .....................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Busulphan Tablets B.P. .........................	The leukaemias
Calciferol Tablets B.P. ..........................	Any disease or condition in a pensioner
Calciferol Solution B.P. ........................	Any disease or condition in a child under the age of twelve years or in a pensioner
Calcium Para-Aminosalicylate B.P.C.	Tuberculosis
Caramiphen Hydrochloride ...................	Parkinsonism
Chlorambucil .......................................	Malignant lymphoma and related conditions
Chloramphenicol Capsules B.P. ............	Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate
Bacterium coli meningitis, if other forms of treatment are unsuccessful
Brucellosis
Granuloma inguinale
Friedlander bacillus infections
Haemophilus influenzae infections
Laryngo-tracheo-bronchitis, acute
Lymphogranuloma venereum
Pre-operative prophylaxis
Salmonella infections
Staphylococcal infections
Surgical conditions of the bowel (pre-operative and post-operative)
Typhoid fever
Typhus and other rickettsial diseases
Urinary tract infections due to gram negative bacilli that are resistant to the Sulphonamides
Whooping cough (Haemophilus pertussis)
As an alternative to the Penicillins in a person sensitive to the Penicillins
Severe gastro-enteritis in a child under the age of sixteen years
Chloramphenicol B.P., Injection ............	A disease or condition specified in this column in relation to Chloramphenicol Capsules
Chloramphenicol B.P., Oral Suspension	A disease or condition, specified in this column in relation to Chloramphenicol Capsules, in a child under the age of twelve years

FIFTH SCHEDULE—continued.

Pharmaceutical Benefit.

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.

Chlorpromazine Hydrochloride B.P. ............

Any disease or condition in a pensioner

Any disease or condition in a patient receiving treatment in or at an approved hospital

With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital

Chlortetracycline Capsules B.P. ..................

As an alternative to the Penicillins in a person sensitive to the Penicillins

Actinomycosis

Amoebiasis

Bacterial endocarditis (Streptococcus faecalis), acute and sub-acute

Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate

Bronchiectasis

Brucellosis

Chancroid

Fibrocystic disease of the pancreas

Granuloma inguinale

Friedlander bacillus infections

Leptospirosis

Lymphogranuloma venereum

Mucoviscidosis

Pneumonia that is resistant both to the Penicillins and the Sulphonamides

Pre-operative prophylaxis

Primary atypical pneumonia

Psittacosis

Puerperal infections

Rat-bite fever (Spirillum minus)

Staphylococcal infections

Trachoma that is resistant to the Sulphonamides

Typhus and other rickettsial diseases

Urinary tract infections due to gram negative bacilli that are resistant to the Sulphonamides

Whooping cough (Haemophilus pertussis)

Chlortetracycline Calcium .....................

A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years

Chlortetracycline B.P. Granules

Cod Liver Oil, B.P.

Any disease or condition in a child under the age of twelve years or in a pensioner

Cod Liver Oil Emulsion B.P. 1953

Corticotrophin Injection B.P.

Corticotrophin Gelatin Injection B.P.

Corticotrophin Zinc Hydroxide Injection B.P.

With the written authority of the Director-General—

A disease or condition specified in this column in relation to Cortisone Injection

The treatment of side effects of corticosteroid therapy

Cortisone Injection B.P. ........................

With the written authority of the Director-General—

Anaemia, acquired haemolytic

Addison’s disease and other forms of adrenocortical hypoplasia

Adrenalectomy, total

Adrenogenital syndrome

FIFTH SCHEDULE—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Cranial arteritis
Cushing’s syndrome, including hyperadrenocorticalism
Dermatitis, acute exfoliative, associated with drug therapy
Dermatomyositis
Encephalomyelitis
Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis proven by lung biopsy
Hansen’s disease
Hepatitis, progressive or continuing, proven by biopsy or biochemistry
Keratoplasty
The leukaemias
Metastatic breast carcinoma
Nephritis, type II.
Nephrotic syndrome
Neuro-myelitis optica
Optic neuritis following removal of tumor of the brain
Panhypopituitarism
Pemphigus
Periarteritis nodosa
Pseudohermaphroditism
Purpura, Henoch’s
Purpura, thrombocytopenic
Rheumatic carditis, acute
Salaam convulsions and hypsarrythmia
Sarcoidosis
Scleroderma
Splenic neutropenia and agranulocytosis
Status asthmaticus
Steroid therapy prior to operation in patients under steroid therapy
Stevens-Johnson syndrome
Still’s disease in a child under the age of sixteen years
Sympathetic ophthalmitis
Systemic lupus erythematosus
Temporal arteritis
Tropical and non-tropical sprue and all forms of mal-absorption associated with those diseases
Ulcerative colitis proven by sigmoidoscopy or radiological report
Uveitis, posterior
Cortisone Tablets B.P. ..........................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Cyanocobalamin Injection B.P. (other than 1,000 microgramme strength)	Established megalocytic anaemias
Cyanocobalamin Injection B.P., 1,000 microgramme strength	Neuroblastoma
Cymogran ............................................	With the written authority of the Director-General, phenylketonuria
Cycloserine ..........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
D-Cycloserine ......................................
Demethylchlortetracycline Hydrochloride	A disease or condition specified in this column in relation to Chlortetracycline Capsules

FIFTH SCHEDULE—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Deoxycortone Acetate B.P. ........................	Addison’s disease Total adrenalectomy
Deoxycortone Acetate Injection B.P.
Deoxycortone Acetate Implant B.P.
Dexamethasone .........................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Dexamethasone Sodium Phosphate
Dextrochlorpheniramine Maleate Syrup	Any disease or condition in a child under the age of twelve years
Dienoestrol B.P., Cream ............................	Any disease or condition in a pensioner
Dienoestrol Tablets B.P. ............................	Carcinoma of the prostate
Mammary carcinoma
Any disease or condition in a pensioner
Diethyl Dithiolisophthalate ........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Diiodohydroxyquinoline B.P., Vaginal Tablet	Trichomonal and monilial vaginitis
Dihydrostreptomycin Sulphate Injection B.P.	An as alternative to Streptomycin Sulphate in a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate
Diloxanide Furoate ....................................	Amoebic dysentery
Disodium Diethylstilboestrol Diphosphate	Carconoma of the prostate
Erythromycin B.P. .....................................	Staphylococcal infections that are resistant both to the Tetracyclines and to the Penicillins
Erythromycin Tablets B.P. .........................
Erythromycin Glucoheptonate
Erythromycin Propionate
Erythromycin B.P., Oral Sachet	Staphylococcal infections that are resistant both to the Tetracyclines and to the Penicillins in a child under the age of twelve years
Erythromycin B.P., Oral Suspension
Erythromycin Stearate, Oral Suspension
Ethinyloestradiol Tablets B.P. ....................	Turner’s syndrome
Pre-menopausal castration syndrome
Any disease or condition in a pensioner
Ethisterone Tablets B.P. .............................	Turner’s syndrome
Habitual abortion
Any disease or condition in a pensioner
Ferric Hydroxide ....................................	Any disease or condition in a child under the age of twelve years
Ferrous Aminoacetosulphate Syrup
Ferrous Gluconate Elixir .........................
Ferrous Succinate Syrup .........................
Fludrocortisone Acetate .............................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Fluoxymesterone .......................................	Mammary carcinoma
Folic Acid B.P. .....................................	Macrocytic anaemia
Folic Acid Tablets B.P. .........................	Sprue or the sprue-like syndrome
Formyl-Tetrahydropteroyl Glutamic Acid	Any disease or condition in a patient receiving treatment in or at an approved hospital
Griseofulvin ..............................................	With the written authority of the Director-General—
For the treatment of any of the following diseases, the diagnosis of which has been confirmed by pathological report:—
Epidermophyton floccosum
Microsporum audouni

FIFTH SCHEDULE—continued.

Pharmaceutical Benefit. Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.

Microsporum canis
Microsporum gypseum
Trichophyton interdigitale
Trichophyton mentagrophytes
Trichophyton rubram
Trichophyton schoenleini
Trichophyton sulphureum
Trichophyton verrucosum
Haemophilus Influenza Bacterial Serum	Any disease or condition in a patient receiving treatment in or at an approved hospital
Hexachlorophene, 3% with Entsufon
Hexachlorophene, 3% with Lissapol
Hexachlorophene, 1.5% with Soap Solution
Hydrocalciferol ....................................	Parathyroid deficiency
Hydrocortisone Injection B.P. ...............	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Hydrocortisone Sodium Succinate B.P.	With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report
Hydrocortisone Sodium Succinate Injection B.P.	Acute adrenal failure due to a medical or surgical crisis
Stevens-Johnson syndrome
Iron Oxide Saccharated .........................	As an alternative to Oral Iron in a person unable to take Oral Iron
Isoniazid Tablets B.P. ...........................	Hansen’s disease
Tuberculosis
Levorphanol Tartrate B.P.C. ..................	Inoperable cancer
Lofenalac .............................................	With the written authority of the Director-General, phenylketonuria
Malt Extract B.P. ..................................	Any disease or condition in a child under the age of twelve years or in a pensioner
Malt Extract with Cod Liver Oil B.P.
Mercaptopurine Tablets B.P. .................	Allergic angiitis
Periarteritis
Systemic lupus erythematosus
The leukaemias
Methicillin ...........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Methyl Androstanolone ........................	Mammary carcinoma
Methylandrostenediol ...........................	Senile osteoporosis proven by radiography
Minafen ...............................................	With the written authority of the Director-General, phenylketonuria
Mustine Injection B.P. ..........................	Malignant lymphoma and related conditions
Nandrolone Phenpropionate ..................	Mammary carcinoma
Neomycin Sulphate B.P., in a form other than Eye Drops	Any disease or condition in a patient receiving treatment in or at an approved hospital
Nicotinamide Tablets B.P. ....................	Any disease or condition in a pensioner
Nicotinic Acid Tablets B.P. ...................	Any disease or condition in a pensioner
Nitrofurantoin ......................................	Urinary tract infections
Nitrofurantoin Suspension .....................	Any urinary tract infection in a child under the age of twelve years
Nitromin ..............................................	Malignant lymphoma and related conditions
Norethandrolone ...................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Novobiocin Calcium B.P. ...................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Novobiocin Sodium B.P. .....................
Novobiocin Tablets B.P. .....................
Nystatin ...............................................	Proven monilia infections

FIFTH SCHEDULE—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Oxytetracycline Tablets B.P.	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Oxytetracycline Injection B.P.
Oxytetracycline and Procaine Injection B.P.
Calcium Di-Oxytetracycline ..................	A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years
Oxytetracycline Paediatric Drops
Pancreatin B.P. .....................................	Fibrous disease of the pancreas
Pancreatico-duodenectomy
Pancrex 5 .............................................	Fibrous disease of the pancreas
Pancreatico-duodenectomy
Para-Aminosalicylic Acid .....................	Tuberculosis
Pethidine and Levallorphan Tartrate ......	Obstetrical use
Phenoxymethylpenicillin B.P., Oral Suspension}
Phenoxymethylpenicillin (Benzathine Salt), Oral Suspension
Phenoxymethylpenicillin Calcium B.P., Oral Suspension	Any disease or condition in a child under the age of twelve years
Phenoxymethylpenicillin (Hydrabamine Salt), Oral Suspension
Phenoxymethylpenicillin. Potassium B.P., Oral Suspension
Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.	Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Phytomenadione Injection B.P. ..............	Antidote to anticoagulants
Piperazine Citrate B.P., Elixir ................	Any disease or condition in a child under the age of twelve years
Prednisolone Disodium Phosphate .........	With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report
Prednisolone Tablets B.P. .....................	With the written authority of the Director-General—
Anaemia, acquired haemolytic
Adrenogenital syndrome
Cranial arteritis
Cushing’s syndrome, including hyperadrenocorticalism
Dermatitis, acute exfoliative, associated with drug therapy
Dermatomyositis
Encephalomyelitis
Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis proven by lung biopsy
Hansen’s disease
Hepatitis, progressive or continuing, proven by biopsy or biochemistry
The leukaemias
Nephritis, typo II.
Nephrotic syndrome
Neuro-myelitis optica
Optic neuritis following removal of tumour of the brain
Panhypopituitarism
Pemphigus
Periarteritis nodosa
Pseudohermaphroditism

FIFTH SCHEDULE—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Purpura, Henoch’s
Purpura, thrombocytopenic
Rheumatic carditis, acute
Salaam convulsions and hypsarrythmia
Sarcoidosis
Scleroderma
Splenic neutropena and agranulocytosis
Status asthmaticus
Steroid therapy prior to operation in patients under steriod therapy
Still’s disease in a child under the age of sixteen years
Sympathetic ophthalmitis
Systemic lupus erythematosus
Tropical and non-tropical sprue and all forms of mal-absorption associated with those diseases
Ulcerative colitis proven by sigmoidoscopy or radiological report
Uveitis, posterior
Methyl Prednisolone .............................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Prednisolone Acetate B.P. .....................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Prednisolone Sodium Hemisuccinate	Any disease or condition in a patient receiving treatment in or at an approved hospital
Prednisone Tablets B.P. ........................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium
Hydroxide Gel. B.P. .............................
Progesterone Injection B.P. ...................	Habitual abortion
Protoveratrines A .................................	Hypertensive crisis
Pyrazinamide .......................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Pyridine Aldoxime Methiodide ..............	Any disease or condition in a patient receiving treatment in or at an approved hospital
Pyridostigmine Injection B.P. ................	Myasthenia gravis
Pyridostigmine Tablets B.P. ..................	Myasthenia gravis
Riboflavine Tablets B.P. .......................	Any disease or condition in a pensioner
Ristocetin .............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Salicylazosulphapyridine ......................	Ulcerative colitis
Sobee ...................................................	With the written authority of the Director-General, galactosaemia
Sodium Aminosalicylate B.P.	Tuberculosis
Sodium Aminosalicylate Tablets B.P.
Sodium Folate ......................................	Macrocytic anaemia
	Sprue or the sprue-like syndrome
Spironolactone......................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Stilboestrol B.P. .................................	Carcinoma of the prostate
Stilboestrol Tablets B.P.......................	Mammary carcinoma
	Any disease or condition in a pensioner

FIFTH SCHEDULE—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Streptomycin Sulphate B.P. .....................	Bacillary dysentery that is resistant to the Sulphonamides
Brucellosis
Chancroid
Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Friedlander bacillus infections
Haemophilus influenzae infections
Plague
Pseudomonas pyocyaneus infections
Rat-bite fever (Streptobacillus moniliformis)
Salmonella infections
Surgical conditions of the bowel (pre-operative and post-operative)
Surgical conditions of the thoracic organs
Tuberculosis
Tularaemia
Urinary tract infections that are resistant to the Sulphonamides
Streptomycin Sulphate Injection B.P. .......	A disease or condition specified in this column in relation to Streptomycin Sulphate
Streptomycin Sulphate B.P. with Benzylpenicillin Sodium, B.P.	Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Sulphadimethoxine Suspension	Any disease or condition in a child under the age of twelve years
Sulphaphenazole Syrup ......................
Sustanon ..............................................
Testosterone Implants B.P. ....................	Castration syndrome
Testosterone Oenanthate .......................	Mammary carcinoma
Testosterone Propionate Injection B.P.	Castration syndrome
Testosterone Propionate B.P.	Kline felter Reifenstein Albright syndrome
Methyltestosterone Tablets B.P.	Mammary carcinoma
Tetracycline with a buffering agent and Amphotericin B	A disease or condition specified in this column in relation to Tetracycline with Nystatin in a child under the age of twelve years
Tetracycline Capsules B.P. .................	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Tetracycline Tablets B.P. ....................
Tetracycline and Procaine Injection B.P.
Tetracycline Hydrochloride B.P. with a buffering agent—Capsules
Tetracycline Injection B.P. .................
Tetracycline with Oleandomycin Capsules
Pyrrolidino-Methyl-Tetracycline
Tetracycline with a buffering agent—Oral Suspension}	A disease or condition, specified in this column in relation to Chloretracycline Capsules, in a child under the age of twelve years
Tetracycline with a buffering agent—Paediatric Drops
Tetracycline with Oleandomycin—Oral Suspension
Tetracycline with Oleandomycin—Paediatric Drops
Tetracycline with Nystatin .........................	Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis
A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules

FIFTH SCHEDULE—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Thyrotropin ................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Triamcinolone ............................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Triethylene Thiosphosphoramide .................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Tretamine ...................................................	Malignant lymphoma and related conditions
Trifluoperazine ...........................................	Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
Trimetaphan Camphorsulphonate .................	Hypotensive for anaesthesia
Triprolidine Hydrochloride, Elixir ................	Any disease or condition in a child under the age of twelve years
Veriloid ......................................................	Hypertensive crisis
Vitamin A Activity with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D	Any disease or condition in a pensioner
Concentrated Vitamin A Solution B.P.	Any disease or condition in a child under the age of twelve years or in a pensioner
Concentrated Vitamin A and D Solution B.P.
Concentrated Vitamin D Solution
Vitamin K ...................................................	As an antidote to anticoagulants

By Authority: A. J. ARTHUR, Commonwealth Government Printer, Canberra.